Trials / Completed
CompletedNCT03741166
Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.
Blood Collection Sub-Study of Exact Sciences Protocol 2018-10: "An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now"
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 871 (actual)
- Sponsor
- Exact Sciences Corporation · Industry
- Sex
- All
- Age
- 45 Years – 49 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this sub-study, 2018-10B, is to collect blood specimens to assess new biomarkers for the detection of Colorectal Cancer (CRC).
Detailed description
Subjects who consent to enroll in Exact Sciences Protocol 2018-10, will be asked to participate in this sub-study. Subjects enrolled in the Exact Sciences Protocol 2018-10, who provide written informed consent to participate in this sub-study, will have a blood sample collected at enrollment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood Sample Collection | Subjects participating in the study will have blood drawn at enrollment. |
Timeline
- Start date
- 2018-11-08
- Primary completion
- 2019-04-05
- Completion
- 2019-04-05
- First posted
- 2018-11-14
- Last updated
- 2021-05-17
Locations
37 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03741166. Inclusion in this directory is not an endorsement.